Matches in SemOpenAlex for { <https://semopenalex.org/work/W2048726054> ?p ?o ?g. }
- W2048726054 endingPage "587" @default.
- W2048726054 startingPage "581" @default.
- W2048726054 abstract "Background/Aims. Both genetic and environmental factors are involved in the pathogenesis of gallstone disease (GD). We aimed to examine the association between symptomatic GD and overweight (body mass index, BMI, 25–30 kg m−2), obesity (BMI > 30 kg m−2), alcohol, smoking and smoke-free tobacco by analysing a large twin population. Methods. The Swedish Twin Registry (STR) was linked to the Swedish Hospital Discharge and Causes of Death Registries for GD and GD-surgery related diagnoses. Weight, height, use of alcohol, smoking and smoke-free tobacco were provided by STR and analysed for possible associations by conditional logistic regression. Results. Overweight and obesity were associated with a significantly higher risk for symptomatic GD in the whole study population (OR 1.86 and OR 3.38; CI: 1.52–2.28 and 2.28–5.02 respectively). High alcohol consumption was associated with a lower risk for GD in the whole population (OR 0.62; CI: 0.51–0.74) with no difference between discordant monozygotic and dizygotic twins (OR 1.08 and OR 0.96; CI: 0.82–1.42 and 0.79–1.16). Smoking or smoke-free tobacco was not correlated with GD. Conclusion. Consistent with epidemiological studies, we found positive associations between BMI and the development of symptomatic GD. High alcohol consumption was associated with a decreased risk against GD. Tobacco use has no impact on GD. The pathogenesis of gallstones is complex [1, 2]. Gallstone formation appears to be a complex trait influenced by genes and environment, and their interaction [3]. Recently we estimated the contributions of genetic and environmental factors to symptomatic gallstone disease (GD) with data from the Swedish Twin Registry (STR) [4]. Genetic effects accounted for 25%, shared environmental effects for 13% and unique environmental effects for 62% [4] of the liability. Overweight is the best-known, age-independent risk factor for GD [5, 6] that itself is genetically influenced [7–9]. Obese subjects are at even higher risk of GD during weight reduction [10]. Delayed gallbladder emptying, and decreased small bowel motility and sensitivity to cholecystokinin have been associated with obesity and GD [11]. Increased risk of cholesterol gallstones formation was confirmed in obese diabetics with hypertriglyceridaemia [12]. Also, plasma cholesterol levels were found to correlate to GD [13]. Alcohol consumption was found to be inversely associated with the risk for GD [14–17]. Moderate alcohol intake may lower the risk for cholesterol GD by reducing bile cholesterol saturation and raising HDL-cholesterol levels [18]. However, the negative effect of alcohol on GD may be overestimated due to reduction of alcohol use because of symptoms related to clinical GD [19] or due to alcohol association with lower obesity [20]. Even more conflicting data are available for the association between GD and smoking. Two recent studies from Japan found either no association between cigarette smoking and GD [21] or an inverse correlation [22]; however, both studies confirmed the assumption that alcohol consumption protects against gallstone formation [21, 22]. Cross-sectional studies from Denmark [23] and Germany [24] either found a significant association between smoking and GD [23] or no relationship between alcohol consumption, tobacco use and GD at all [24]. Case–control studies from UK [25] and Australia [26] described symptomatic GD both as a disease of nonsmokers [25] and of cigarette smoking women [26], the latter surprisingly at maximal increased risk when young and currently smoking [26]. Investigations on GD risk factors should ideally adjust the results for potential effects by genetic predisposition and shared environmental factors. The co-twin control method, which compares twins who are discordant for a disease, provides a valid tool to achieve this aim. The STR, the largest population-based twin registry in the world, offers a particularly strong basis for exploring the importance of potential lifestyle risk factors with controlling for genetic background [27]. Our aim now was to: (i) examine associations between body mass index (BMI), alcohol and tobacco habits (smoking and use of smoke-free tobacco) and GD and (ii) to investigate whether potential associations between overweight or obesity, alcohol, tobacco and GD are confounded by shared environmental factors, by conducting a co-twin analysis. The STR was linked to the Swedish Hospital Discharge and Causes of Death Registries for twins born between 1886 and 1958 as recently described [4]. The study population comprised all 58 402 twins born 1886–1958 in the STR, consisting of 19 950 monozygotic (MZ) twins, 33 464 dizygotic (DZ) twins, 4988 twins of unknown zygosity; 27 692 were male and 30 710 female. In the separate analysis for each potential risk factor, we included those same-sexed twins in the STR who responded to a questionnaire in 1961 or 1973 regarding the risk factor studied [27]. Twins born between 1886 and 1925 (cohort C1) were evaluated in 1961 for smoking habits, in 1963 for smoking habits and BMI, and in 1967 and 1970 for smoking habits, alcohol and BMI [27]. If data on the same variable were available at different times, the most recent value was used. The 1973 questionnaire evaluated twins born between 1926 and 1958 (cohort C2) for alcohol, BMI, and smoking and smoke-free tobacco habits [27]. The follow-up times were 1 January, 1970 to 31 December, 2002 for C1; and 1 January, 1974 to 31 December, 2002 for C2. To avoid bias through later lifestyle changes, we excluded twins that had answered the questionnaires after the diagnosis of GD was made. Body mass index (kg m−2) data were categorized according to the WHO [28] as normal (18.5–24.9), overweight (25.0–29.9) and obese (≥30.0). Alcohol was stratified according to the total amount consumed [29, 30] as nondrinkers (0 g month−1 for both women and men), moderate consumers (>0–1800 g month−1 for women, >0–2400 g month−1 for men), and high consumers (>1800 g month−1 for women, >2400 g month−1 for men), i.e. statistically significantly associated with increased risk for liver disease [29, 30]. Smoking was categorized as never, previous or current for all forms of smoking. The same principle was applied to smoke-free tobacco (snuff), an oral tobacco preparation popular in Sweden. In the study population of 58 402 twins, we identified 1666 twins with GD. In this cohort, logistic regression analysis for gender, age, zygosity, BMI and alcohol and smoking habits was performed, including both concordant and discordant pairs, regardless of zygosity status. Dependence within twin pairs was accounted for by using Generalized Estimation Equation models (GEE) with SAS PROC GENMOD [31]. Co-twin comparison of same-sexed twins was performed in 1527 cases with GD and where the co-twin was without a history of GD. The analysis was subdivided in MZ and DZ twin pairs to investigate genetic or shared environmental factors. The co-twin analyses were performed with conditional logistic regression by the maximum likelihood method using SAS PROC PHREG [32, 33]. Odds ratios (OR) and 95% confidence intervals (CI) were calculated. By investigating the association within twin pairs discordant for GD, the influence of genetic and shared environmental factors is substantially reduced. Twins within the same pair share the same environment during infancy and childhood, so differences within MZ and DZ twin pairs should be independent of common environmental factors. In addition, within MZ twin pairs, differences are independent of genetic factors. If there were a causal effect of the risk factor on GD, we would expect the same association in GD discordant MZ and DZ twin pairs as in the whole study population that served as controls. On the other hand, if genetic effects were confounding the association we would expect the same association in discordant DZ twin pairs as well as in co-twins from the whole study population, but not in discordant MZ twin pairs. If shared environmental factors were confounding the association we would expect no difference between MZ and DZ twin pairs but a different association in co-twins from the whole study population. These conclusions are based on the assumption that any differences existing between MZ co-twins must necessarily originate from environmental influences including shared environmental factors. Differences between DZ co-twins could both be due to genetic and early environmental factors. The distributions of the covariates for twins with (cases) and without GD (controls) are presented in Table 1. There were more overweight twins with than without GD (32% vs. 23%). Moderate to high alcohol consumption was slightly more prevalent in twins without GD. The majority of the twins did not consume any tobacco products and the pattern of tobacco consumption was similar in the two groups. In the cohort study, we included all twins and calculated the risk for GD and evaluated each parameter per se in comparison with unrelated twins. The crude risks for BMI, smoking, smoke-free tobacco and alcohol and GD are presented in Table 2. Women had a statistically significant, more than doubled, risk for GD. Overweight and obese twins had a higher risk for GD (OR1.86 and 3.38), which was statistically significant different from twins with normal BMI. Alcohol consumption at high levels had a statistically significant, negative effect against GD (OR 0.62). Previous or current smoking or use of smoke-free tobacco did not have a statistically significant impact on the development of GD (Table 2). Results from the additional within-pair analyses, aimed to control for potential unmeasured confounding, are presented in Table 3. When we compared the cases with their healthy co-twins, we found a statistically significant decreased risk for GD when the healthy DZ co-twin was obese. No statistically significant difference was found in the association within discordant MZ and DZ twins regarding overweight or alcohol and GD. These results indicate that the positive association between overweight and GD, as well as the negative association of high alcohol consumption on GD observed in the cohort analyses probably have been confounded by shared environmental factors. The present study aimed to estimate the impact of BMI, alcohol, smoking and smoke-free tobacco for the development of symptomatic GD. Data from the cohort study confirmed our previous finding that women are at higher risk for GD [4]. Here we also could show that the risk increases with increasing BMI. Overweight and especially obese twins have a substantially higher risk for GD (OR 1.86 and 3.38 respectively). Because we had data on twins, we could go one step further and investigate the aetiology of the association between BMI and GD. There were only minor nonsignificant increases in risks for GD in discordant DZ and MZ overweight twins (OR 1.17 and OR 1.16) with no difference between the zygosity groups. In contrast to the analysis with unrelated control twins, the co-twin analysis suggested significantly lower (OR 0.83) risk for GD for DZ obese twins. Obese MZs also had a lower (OR 0.79) yet not significant lower risk for GD. This surprising finding seems to contradict the association between GD and BMI. One might speculate that the obese twin of a DZ twin brother or sister did not present with typical gallstone symptoms or that he/she restrained from further evaluation and surgery for gallstones as he/she (or the physician involved) became afraid of possible discomfort and/or surgical complication. In both overweight and obese twins there were no differences between the zygosity groups, but there was a difference compared to the whole population, suggesting that shared environmental factors confound the association between BMI and GD. Possible mechanisms for the shared environmental effect could be diet during childhood or maternal dietary or alcohol habits during pregnancy that influence both BMI and GD later in life, and could be an explanation to our previous findings of shared environmental factors for GD [4]. We were not able to unequivocally define the impact of alcohol consumption on GD. The OR was significantly decreased in twins with higher alcohol consumption (OR 0.62; CI: 0.51–0.74) when compared to twins with moderate alcohol consumption. However, there were no differences between twins with moderate alcohol consumption and the totally alcohol abstaining twins. Previous studies suggest that frequent, moderate intake of alcohol is associated with a lower risk for GD both in men and women [14–17]. In the high alcohol consumption groups, there was no difference within discordant DZ and MZ twins (OR 0.96 and OR 1.08; CI: 0.79–1.16 and 0.82–1.42) suggesting that this negative association of alcohol and GD effect is confounded by shared environment. As to tobacco use, we did not find any significant association between the risk of GD and current or previous smoking or use of smoke-free tobacco, which is consistent with some [21, 24] but not all epidemiologic studies [21–26]. However, our data on tobacco habits, especially on smoke-free tobacco, were scarce, limiting the power of this evaluation. Our study of lifestyle-related environmental factors, which includes overweight and obesity, has limitations. In particular, our study does not answer the question what fractions of GD specifically are due to obesity or heredity. This question could be addressed in a bivariate quantitative analysis that includes twins without GD. However, this was not possible in our study as the data set concerning BMI (and alcohol and smoking habits) of the large majority of twins without GD is incomplete. In addition, information about BMI, alcohol, smoking and smoke-free tobacco was self-reported, and it is possible that data on weight and drug habits were underestimated, in particular in the higher ranges. A large proportion of self-reports actually was incomplete and not suitable for evaluation which diminished the already relatively modest number (1666) of cases with symptomatic GD. Furthermore, the question on smoke-free tobacco habits was only addressed to cohort C1 and thus leading to a large number of missing values. Thus, despite the large number of twins screened, the study size might not have had sufficient power to reveal possibly significant differences. Twins that actually did answer the questionnaire have been assumed to be representative of the whole population, which would be a potential bias factor if this were not the case. Another factor not studied was the impact of co-morbidity, i.e. high BMI or cardiopulmonary disease, on the hospitalization decision. As the laparoscopic era progressed during the 90s, some patients might have been operated on an ambulatory basis and thus were not accounted for in the Hospital Discharge Registry whereas patients with risk factors, e.g. high BMI, certainly were hospitalized. On the other hand, patients with severe confounding illness, e.g. advanced lung disease, and thus high operative risk were more likely to be treated conservatively on an outpatient basis. Finally, the Hospital Discharge Registry is complete only from 1987 on. Although including inpatients retroactively, some data were unavailable for many of the operated patients in the older cohort. Despite all these limitations, the present study is strengthened by its long follow-up time of upto 40 years and by the absence of recall bias as potential risk or protective factors were registered prior to the diagnosis of GD. In conclusion, we confirm the association between increasing BMI and GD as well as a negative effect of increased alcohol consumption on GD when alcohol consumption reached levels associated with increased risk for liver disease. The co-twin analysis indicates in both cases that shared environmental factors rather than genetic mechanisms probably confound these associations. Diet during childhood, maternal alcohol habits or dietary factors during pregnancy could be of significance, though no data are available on the potential impact of these factors. Smoking or use of smoke-free tobacco did not have a significant impact on symptomatic GD and larger studies are required to identify a possible association. No conflict of interest was declared. The Swedish Twin Registry is supported by grants from the Department of Higher Education, the Swedish Scientific Council and AstraZeneca. This study was also supported by grants from the Swedish Medical Society and Karolinska Institutet." @default.
- W2048726054 created "2016-06-24" @default.
- W2048726054 creator A5009108718 @default.
- W2048726054 creator A5040586297 @default.
- W2048726054 creator A5046450925 @default.
- W2048726054 creator A5056353968 @default.
- W2048726054 creator A5078832883 @default.
- W2048726054 date "2007-11-01" @default.
- W2048726054 modified "2023-10-17" @default.
- W2048726054 title "Body mass index, alcohol, tobacco and symptomatic gallstone disease: a Swedish twin study" @default.
- W2048726054 cites W125883026 @default.
- W2048726054 cites W1829438466 @default.
- W2048726054 cites W1968851560 @default.
- W2048726054 cites W1986234188 @default.
- W2048726054 cites W1990187461 @default.
- W2048726054 cites W1995618284 @default.
- W2048726054 cites W1998979801 @default.
- W2048726054 cites W2009114380 @default.
- W2048726054 cites W2009578388 @default.
- W2048726054 cites W2015306246 @default.
- W2048726054 cites W2018706910 @default.
- W2048726054 cites W2042580916 @default.
- W2048726054 cites W2050384933 @default.
- W2048726054 cites W2054093049 @default.
- W2048726054 cites W2065282693 @default.
- W2048726054 cites W2068253759 @default.
- W2048726054 cites W2075324589 @default.
- W2048726054 cites W2076070753 @default.
- W2048726054 cites W2081106458 @default.
- W2048726054 cites W2088799713 @default.
- W2048726054 cites W2101739792 @default.
- W2048726054 cites W2104129218 @default.
- W2048726054 cites W2107479916 @default.
- W2048726054 cites W2127403601 @default.
- W2048726054 cites W2135155547 @default.
- W2048726054 cites W2151570089 @default.
- W2048726054 cites W2153796577 @default.
- W2048726054 cites W3193045668 @default.
- W2048726054 cites W4242374436 @default.
- W2048726054 doi "https://doi.org/10.1111/j.1365-2796.2007.01860.x" @default.
- W2048726054 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17908165" @default.
- W2048726054 hasPublicationYear "2007" @default.
- W2048726054 type Work @default.
- W2048726054 sameAs 2048726054 @default.
- W2048726054 citedByCount "55" @default.
- W2048726054 countsByYear W20487260542012 @default.
- W2048726054 countsByYear W20487260542013 @default.
- W2048726054 countsByYear W20487260542014 @default.
- W2048726054 countsByYear W20487260542015 @default.
- W2048726054 countsByYear W20487260542016 @default.
- W2048726054 countsByYear W20487260542017 @default.
- W2048726054 countsByYear W20487260542018 @default.
- W2048726054 countsByYear W20487260542019 @default.
- W2048726054 countsByYear W20487260542020 @default.
- W2048726054 countsByYear W20487260542022 @default.
- W2048726054 countsByYear W20487260542023 @default.
- W2048726054 crossrefType "journal-article" @default.
- W2048726054 hasAuthorship W2048726054A5009108718 @default.
- W2048726054 hasAuthorship W2048726054A5040586297 @default.
- W2048726054 hasAuthorship W2048726054A5046450925 @default.
- W2048726054 hasAuthorship W2048726054A5056353968 @default.
- W2048726054 hasAuthorship W2048726054A5078832883 @default.
- W2048726054 hasBestOaLocation W20487260541 @default.
- W2048726054 hasConcept C126322002 @default.
- W2048726054 hasConcept C136764020 @default.
- W2048726054 hasConcept C185592680 @default.
- W2048726054 hasConcept C2777382242 @default.
- W2048726054 hasConcept C2779134260 @default.
- W2048726054 hasConcept C2780221984 @default.
- W2048726054 hasConcept C2781066024 @default.
- W2048726054 hasConcept C3018430727 @default.
- W2048726054 hasConcept C41008148 @default.
- W2048726054 hasConcept C55493867 @default.
- W2048726054 hasConcept C71924100 @default.
- W2048726054 hasConceptScore W2048726054C126322002 @default.
- W2048726054 hasConceptScore W2048726054C136764020 @default.
- W2048726054 hasConceptScore W2048726054C185592680 @default.
- W2048726054 hasConceptScore W2048726054C2777382242 @default.
- W2048726054 hasConceptScore W2048726054C2779134260 @default.
- W2048726054 hasConceptScore W2048726054C2780221984 @default.
- W2048726054 hasConceptScore W2048726054C2781066024 @default.
- W2048726054 hasConceptScore W2048726054C3018430727 @default.
- W2048726054 hasConceptScore W2048726054C41008148 @default.
- W2048726054 hasConceptScore W2048726054C55493867 @default.
- W2048726054 hasConceptScore W2048726054C71924100 @default.
- W2048726054 hasIssue "5" @default.
- W2048726054 hasLocation W20487260541 @default.
- W2048726054 hasLocation W20487260542 @default.
- W2048726054 hasOpenAccess W2048726054 @default.
- W2048726054 hasPrimaryLocation W20487260541 @default.
- W2048726054 hasRelatedWork W2000467310 @default.
- W2048726054 hasRelatedWork W2073005298 @default.
- W2048726054 hasRelatedWork W213562313 @default.
- W2048726054 hasRelatedWork W2158040296 @default.
- W2048726054 hasRelatedWork W2166332686 @default.
- W2048726054 hasRelatedWork W2349491861 @default.
- W2048726054 hasRelatedWork W2349832644 @default.
- W2048726054 hasRelatedWork W2366069483 @default.